Topic4 articles

Quality

Field notes and regulatory analysis tagged with Quality.

Quality2026 · 05

Medical Marijuanas UK: The Stability Data Gap & MHRA Expectations

The UK medical marijuanas sector is maturing, bringing increased scrutiny on product quality lifecycle. MHRA expectations around stability data, while clear in pharmaceutical products, often create a significant practical and financial dilemma for cannabis operators navigating the nuances of ICH Q1A and British Pharmacopoeia monographs.

6 min

Quality2026 · 05

Ensuring Longevity: Stability Programs & Cannabis Long Term Effects

The UK medicinal cannabis sector faces a critical challenge: ensuring product quality and safety over time. While the immediate therapeutic effects are crucial, understanding and mitigating cannabis long term effects on product efficacy and safety through rigorous stability testing is paramount for regulatory compliance and patient trust.

6 min

Quality2026 · 05

Navigating UK Medicinal Cannabis GMP: ICH Q1A and Stability Testing

As the UK medicinal cannabis sector matures into late 2026, the bedrock of compliance remains robust manufacturing and robust data. This article drills down into GMP, specifically focusing on the critical role of ICH Q1A guidelines and stability testing in ensuring product quality and regulatory adherence. Navigating MHRA and Home Office expectations requires deep understanding.

7 min

Quality2025 · 02

UK Medical Cannabis Stability Testing: ICH Guidelines & Compliance

Stability studies, ICH alignment and British Pharmacopoeia obligations — what UK medical cannabis operators must demonstrate to stay compliant.

7 minUpdated 2026 · 05